PharmEnable supports early drug discovery programs by providing a rapid, cost efficient, and effective platform to identify new hit candidates. They use their unique and diverse virtual compound library in conjunction with our computational screening programs, to identify novel active chemical starting points against the most challenging biological targets
Location: United Kingdom, England
Total raised: $9.99M
Investors 6
| Date | Name | Website |
| - | o2h ventur... | o2hventure... |
| - | Syndicate ... | syndicater... |
| - | Cambridge ... | cambridgea... |
| - | Parkwalk A... | parkwalkad... |
| 22.06.2023 | MP Healthc... | mp-healthc... |
| - | Martlet | martletcap... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 22.05.2023 | Seed | $7.5M | - |
| 30.06.2020 | - | $2.49M | - |
Mentions in press and media 12
| Date | Title | Description | Source |
| 22.05.2023 | Mitsubishi backs PharmEnable in £6m pre-Series A | Drug discovery startup PharmEnable has secured $7.5m (£6m) in a pre-Series A raise led by Mitsubishi... | uktech.new... |
| 22.05.2023 | PharmEnable Closes $7.5M Pre-Series Financing | PharmEnable, a Cambridge, UK-based drug discovery company focused on chemical novelty, diversity and... | finsmes.co... |
| 22.05.2023 | PharmEnable Closes $7.5M Financing led by MP Healthcare to D... | - | globenewsw... |
| 22.05.2023 | PharmEnable closes $7.5m funding round to scale drug hunt | - | cambridgea... |
| 22.09.2021 | Introducing: the 32 companies joining the Applied AI program... | We are excited to announce the 32 AI companies selected for the third iteration of Tech Nation’s App... | technation... |
| 16.07.2021 | PharmEnable and LifeArc partner to discover novel oral antiv... | PharmEnable and LifeArc partner to discover novel oral antiviral drugs to treat coronaviruses 16-07... | cambridgen... |
| 15.07.2021 | LifeArc and PharmEnable team up to discover novel oral antiv... | Cambridge, UK, 15 July 2021 – PharmEnable, an AI drug discovery company unlocking challenging biolog... | lifearc.or... |
| 12.01.2021 | Sosei Heptares and PharmEnable collaborate for AI-driven dru... | Sosei Heptares and PharmEnable collaborate for AI-driven drug discovery against challenging GPCR tar... | cambridgen... |
| 30.06.2020 | Cambridge spin-out PharmEnable raises £1.8m for drug discove... | PharmEnable, a Cambridge-based drug discovery company using advanced medicinal chemistry and AI-enab... | cambridgen... |
| 30.06.2020 | Cambridge spin-out PharmEnable raises £1.8m for drug discove... | Cambridge spin-out PharmEnable raises £1.8m for drug discovery expansion 30-06-2020 PharmEnable, a... | cambridgen... |
Show more